BACKGROUND: The present maintenance study investigated whether the reduction in hypochondriacal complaints after initial treatment with CBT or paroxetine sustained during a follow-up period and whether psychiatric severity at pretest predicted the course of hypochondriacal symptoms. METHOD: A naturalistic follow-up period of 18 months after a 16-week RCT consisting of 33 patients initially allocated to a CBT condition and 29 patients to aparoxetine condition. The main outcome measure was the Whiteley Index. RESULTS: The initial treatment effect of CBT and paroxetine sustained during the follow-up period. No significant differences between CBT and paroxetine were found. Treatment course could not be predicted by psychiatric comorbidity. CONCLUSION:CBT and paroxetine are both effective treatments for hypochondriasis in the long term.
RCT Entities:
BACKGROUND: The present maintenance study investigated whether the reduction in hypochondriacal complaints after initial treatment with CBT or paroxetine sustained during a follow-up period and whether psychiatric severity at pretest predicted the course of hypochondriacal symptoms. METHOD: A naturalistic follow-up period of 18 months after a 16-week RCT consisting of 33 patients initially allocated to a CBT condition and 29 patients to a paroxetine condition. The main outcome measure was the Whiteley Index. RESULTS: The initial treatment effect of CBT and paroxetine sustained during the follow-up period. No significant differences between CBT and paroxetine were found. Treatment course could not be predicted by psychiatric comorbidity. CONCLUSION:CBT and paroxetine are both effective treatments for hypochondriasis in the long term.
Authors: Kari-Elise Frøystad Veddegjærde; Børge Sivertsen; Jens Christoffer Skogen; Otto Robert Frans Smith; Ingvard Wilhelmsen Journal: BJPsych Open Date: 2020-04-29
Authors: Lyonne N L Zonneveld; Yanda R van Rood; Cornelis G Kooiman; Reinier Timman; Adriaan van 't Spijker; Jan J V Busschbach Journal: BMC Public Health Date: 2012-10-08 Impact factor: 3.295